This tool looks for unlabeled Wikidata items in your language. It starts with a Wikidata item, looks at all the associated Wikipedia pages, the links on all those pages, and lists the Wikidata items corresponding to the link targets.
Wikidata item
Q
(Example | In the news)
Language code

Q58218746 - No label in !

Searching link targets on 4 Wikipedias...

Toggle existing labels
ItemLabel []WikilabelsLink #
Q192093 [CC | ]No label in !Anatomical Therapeutic Chemical Classification System | سیستم طبقه‌بندی شیمیایی آناتومیکی درمان | Anatomisch-Therapeutisch-Chemisches Klassifikationssystem3
Q102507 [CC | ]No label in !CAS Registry Number | شماره ثبت سی‌ای‌اس | CAS-Nummer3
Q103537 [CC | ]No label in !Antigen | آنتی‌ژن2
Q83147 [CC | ]No label in !Chemical formula | فرمول شیمیایی2
Q750619 [CC | ]No label in !Chugai Pharmaceutical Co. | Chūgai Seiyaku2
Q1122544 [CC | ]No label in !DrugBank2
Q204711 [CC | ]No label in !Food and Drug Administration2
Q145623 [CC | ]No label in !Molar mass | جرم مولی2
Q422248 [CC | ]No label in !Monoclonal antibody | Monoklonaler Antikörper2
Q2751034 [CC | ]No label in !Mouse | موش2
Q1367466 [CC | ]No label in !Orphan drug | Orphan-Arzneimittel2
Q425154 [CC | ]No label in !Tocilizumab2
Q6593799 [CC | ]No label in !Unique Ingredient Identifier | شناسه محتویات یکتا2
Q1860 [CC | ]No label in !زبان انگلیسی | ଇଂରାଜୀ ଭାଷା2
Q611458 [CC | ]No label in !سندرم دویک | Neuromyelitis-optica-Spektrum-Erkrankungen2
Q434115 [CC | ]No label in !ATC code L041
Q19903170 [CC | ]No label in !Abrilumab1
Q348260 [CC | ]No label in !Adalimumab1
Q2481887 [CC | ]No label in !Adjuvant therapy1
Q3606143 [CC | ]No label in !Afelimomab1
Q4745081 [CC | ]No label in !American Society of Health-System Pharmacists1
Q48975957 [CC | ]No label in !Andecaliximab1
Q15708296 [CC | ]No label in !Anifrolumab1
Q3458624 [CC | ]No label in !Anrukinzumab1
Q4780240 [CC | ]No label in !Apolizumab1
Q3624931 [CC | ]No label in !Aselizumab1
Q20707748 [CC | ]No label in !Atezolizumab1
Q3629019 [CC | ]No label in !Atorolimumab1
Q8084905 [CC | ]No label in !Autoimmune disease1
Q21083261 [CC | ]No label in !Avelumab1
Q418702 [CC | ]No label in !Basiliximab1
Q1996249 [CC | ]No label in !Belimumab1
Q3638304 [CC | ]No label in !Benralizumab1
Q30314044 [CC | ]No label in !Bermekimab1
Q4895713 [CC | ]No label in !Bertilimumab1
Q1871058 [CC | ]No label in !Besilesomab1
Q60785566 [CC | ]No label in !Bimekizumab1
Q48850555 [CC | ]No label in !Bleselumab1
Q28209015 [CC | ]No label in !Brazikumab1
Q3644426 [CC | ]No label in !Briakinumab1
Q4972934 [CC | ]No label in !Brodalumab1
Q55606493 [CC | ]No label in !Camidanlumab tesirine1
Q60785565 [CC | ]No label in !Camrelizumab1
Q3655009 [CC | ]No label in !Canakinumab1
Q5043094 [CC | ]No label in !Carlumab1
Q5057039 [CC | ]No label in !Cedelizumab1
Q55606818 [CC | ]No label in !Cemiplimab1
Q412909 [CC | ]No label in !Certolizumab pegol1
Q3601001 [CC | ]No label in !Clazakizumab1
Q3680492 [CC | ]No label in !Clenoliximab1
Q30612 [CC | ]No label in !Clinical trial1
Q5133746 [CC | ]No label in !ClinicalTrials.gov1
Q28209568 [CC | ]No label in !Crizanlizumab1
Q412920 [CC | ]No label in !Daclizumab1
Q5209305 [CC | ]No label in !DailyMed1
Q85757472 [CC | ]No label in !Dostarlimab1
Q5308897 [CC | ]No label in !Drug nomenclature1
Q5308945 [CC | ]No label in !Drugs.com1
Q5315925 [CC | ]No label in !Dupilumab1
Q19904005 [CC | ]No label in !Durvalumab1
Q421617 [CC | ]No label in !Eculizumab1
Q418270 [CC | ]No label in !Efalizumab1
Q10423561 [CC | ]No label in !Eldelumab1
Q923443 [CC | ]No label in !Elsilimomab1
Q28209889 [CC | ]No label in !Emapalumab1
Q3730737 [CC | ]No label in !Epratuzumab1
Q3731886 [CC | ]No label in !Erlizumab1
Q5404888 [CC | ]No label in !Etrolizumab1
Q3739511 [CC | ]No label in !Faralimomab1
Q5425270 [CC | ]No label in !Fast track (FDA)1
Q5446179 [CC | ]No label in !Fezakinumab1
Q107548513 [CC | ]No label in !First-in-class medication1
Q19904185 [CC | ]No label in !Fletikumab1
Q3747524 [CC | ]No label in !Fontolizumab1
Q3753116 [CC | ]No label in !Fresolimumab1
Q123162030 [CC | ]No label in !Frexalimab1
Q966412 [CC | ]No label in !Galiximab1
Q3758982 [CC | ]No label in !Gavilimomab1
Q899140 [CC | ]No label in !Genentech1
Q5554924 [CC | ]No label in !Gevokizumab1
Q413879 [CC | ]No label in !Golimumab1
Q3773206 [CC | ]No label in !Gomiliximab1
Q15708315 [CC | ]No label in !Guselkumab1
Q5939625 [CC | ]No label in !Humanized antibody1
Q60785567 [CC | ]No label in !Ianalumab1
Q3791531 [CC | ]No label in !Ibalizumab1
Q1059 [CC | ]No label in !Immune system1
Q1455316 [CC | ]No label in !Immunosuppression1
Q496997 [CC | ]No label in !Indication (medicine)1
Q25326696 [CC | ]No label in !Inebilizumab1
Q415264 [CC | ]No label in !Infliximab1
Q3799026 [CC | ]No label in !Inolimomab1
Q194908 [CC | ]No label in !Interleukin1
Q824258 [CC | ]No label in !International nonproprietary name1
Q2459042 [CC | ]No label in !Ipilimumab1
Q6094826 [CC | ]No label in !Itolizumab1
Q13574436 [CC | ]No label in !Ixekizumab1
Q909442 [CC | ]No label in !KEGG1
Q3814375 [CC | ]No label in !Keliximab1
Q6482369 [CC | ]No label in !Lampalizumab1
Q25326708 [CC | ]No label in !Lanadelumab1
Q3829321 [CC | ]No label in !Lebrikizumab1
Q3830104 [CC | ]No label in !Lemalesomab1
Q25326692 [CC | ]No label in !Lenzilumab1
Q3830773 [CC | ]No label in !Lerdelimumab1
Q827023 [CC | ]No label in !Lesion1
Q48850536 [CC | ]No label in !Letolizumab1
Q6545898 [CC | ]No label in !Ligelizumab1
Q104178616 [CC | ]No label in !Lirentelimab1
Q6557650 [CC | ]No label in !Lirilumab1
Q217094 [CC | ]No label in !List of withdrawn drugs1
Q45248409 [CC | ]No label in !Lokivetmab1
Q20706900 [CC | ]No label in !Lulizumab pegol1
Q3840604 [CC | ]No label in !Lumiliximab1
Q3850818 [CC | ]No label in !Maslimomab1
Q6794291 [CC | ]No label in !Mavrilimumab1
Q3306175 [CC | ]No label in !Mepolizumab1
Q6823403 [CC | ]No label in !Metelimumab1
Q55641096 [CC | ]No label in !Mirikizumab1
Q6890447 [CC | ]No label in !Mogamulizumab1
Q14605026 [CC | ]No label in !Morolimumab1
Q6961860 [CC | ]No label in !Namilumab1
Q386119 [CC | ]No label in !Natalizumab1
Q6996050 [CC | ]No label in !Nerelimomab1
Q7041828 [CC | ]No label in !Nivolumab1
Q111370719 [CC | ]No label in !Nivolumab/relatlimab1
Q2013780 [CC | ]No label in !Ocrelizumab1
Q7078368 [CC | ]No label in !Odulimomab1
Q47123037 [CC | ]No label in !Oleclumab1
Q7088501 [CC | ]No label in !Olokizumab1
Q415392 [CC | ]No label in !Omalizumab1
Q7108506 [CC | ]No label in !Otelixizumab1
Q7115169 [CC | ]No label in !Oxelumab1
Q7116652 [CC | ]No label in !Ozoralizumab1
Q48851069 [CC | ]No label in !Pamrevlumab1
Q7141848 [CC | ]No label in !Pascolizumab1
Q7144397 [CC | ]No label in !Pateclizumab1
Q13896859 [CC | ]No label in !Pembrolizumab1
Q7166882 [CC | ]No label in !Perakizumab1
Q7179565 [CC | ]No label in !Pexelizumab1
Q7180990 [CC | ]No label in !Phases of clinical research1
Q7191298 [CC | ]No label in !Pidilizumab1
Q269829 [CC | ]No label in !Placebo1
Q7200426 [CC | ]No label in !Placulumab1
Q25326699 [CC | ]No label in !Plozalizumab1
Q1057079 [CC | ]No label in !Pregnancy category1
Q1643563 [CC | ]No label in !Prescription drug1
Q7242994 [CC | ]No label in !Priliximab1
Q19652 [CC | ]No label in !Public domain1
Q7271973 [CC | ]No label in !Quilizumab1
Q55641547 [CC | ]No label in !Ravulizumab1
Q573538 [CC | ]No label in !Regulation of therapeutic goods1
Q58315670 [CC | ]No label in !Relatlimab1
Q7315650 [CC | ]No label in !Reslizumab1
Q117349369 [CC | ]No label in !Retifanlimab1
Q25112466 [CC | ]No label in !Risankizumab1
Q7366071 [CC | ]No label in !Rontalizumab1
Q621636 [CC | ]No label in !Route of administration1
Q3941929 [CC | ]No label in !Rovelizumab1
Q120491843 [CC | ]No label in !Rozanolixizumab1
Q7380420 [CC | ]No label in !Ruplizumab1
Q7408522 [CC | ]No label in !Samalizumab1
Q7424081 [CC | ]No label in !Sarilumab1
Q7444755 [CC | ]No label in !Secukinumab1
Q7511830 [CC | ]No label in !Sifalimumab1
Q7525805 [CC | ]No label in !Siplizumab1
Q7530673 [CC | ]No label in !Sirukumab1
Q60785560 [CC | ]No label in !Spartalizumab1
Q111172579 [CC | ]No label in !Spesolimab1
Q7598349 [CC | ]No label in !Standard for the Uniform Scheduling of Medicines and Poisons1
Q60785670 [CC | ]No label in !Sutimlimab1
Q7672878 [CC | ]No label in !Tabalumab1
Q7679593 [CC | ]No label in !Talizumab1
Q7692226 [CC | ]No label in !Technetium (99mTc) fanolesomab1
Q3976820 [CC | ]No label in !Technetium (99mTc) sulesomab1
Q113366205 [CC | ]No label in !Teclistamab1
Q7697277 [CC | ]No label in !Telimomab aritox1
Q7699688 [CC | ]No label in !Teneliximab1
Q7701358 [CC | ]No label in !Teplizumab1
Q25326702 [CC | ]No label in !Tezepelumab1
Q15708331 [CC | ]No label in !Tildrakizumab1
Q28209583 [CC | ]No label in !Tislelizumab1
Q7825392 [CC | ]No label in !Toralizumab1
Q7833105 [CC | ]No label in !Tralokinumab1
Q7837825 [CC | ]No label in !Tregalizumab1
Q7838098 [CC | ]No label in !Tremelimumab1
Q21098907 [CC | ]No label in !Ulocuplumab1
Q7900382 [CC | ]No label in !Urelumab1
Q420305 [CC | ]No label in !Ustekinumab1
Q7915305 [CC | ]No label in !Vapaliximab1
Q21098904 [CC | ]No label in !Varlilumab1
Q7917100 [CC | ]No label in !Vatelizumab1
Q7918002 [CC | ]No label in !Vedolizumab1
Q7920695 [CC | ]No label in !Vepalimomab1
Q7936102 [CC | ]No label in !Visilizumab1
Q25326713 [CC | ]No label in !Vobarilizumab1
Q37155 [CC | ]No label in !WHO Model List of Essential Medicines1
Q8066254 [CC | ]No label in !Zanolimumab1
Q8073564 [CC | ]No label in !Zolimomab aritox1
Q79460 [CC | ]No label in !Antikörper1
Q623090 [CC | ]No label in !Aquaporine1
Q912807 [CC | ]No label in !Arzneistoff1
Q502961 [CC | ]No label in !Astrozyt1
Q178999 [CC | ]No label in !Axon1
Q221694 [CC | ]No label in !Blut-Hirn-Schranke1
Q110084 [CC | ]No label in !Blutserum1
Q56646 [CC | ]No label in !CHO-Zellen1
Q1186697 [CC | ]No label in !Demyelinisation1
Q25670 [CC | ]No label in !Digital Object Identifier1
Q458 [CC | ]No label in !Europäische Union1
Q1073 [CC | ]No label in !Gehirn1
Q898365 [CC | ]No label in !Glykosylierung1
Q412889 [CC | ]No label in !Interleukin-61
Q16 [CC | ]No label in !Kanada1
Q496812 [CC | ]No label in !Leukopenie1
Q54196 [CC | ]No label in !Liquor cerebrospinalis1
Q40936 [CC | ]No label in !PH-Wert1
Q9606 [CC | ]No label in !Rückenmark1
Q39 [CC | ]No label in !Schweiz1
Q186029 [CC | ]No label in !Sehnerv1
Q2035485 [CC | ]No label in !Subkutan1
Q212354 [CC | ]No label in !Zytokin1